NCT05181696 Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
| NCT ID | NCT05181696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Osijek University Hospital |
| Condition | COVID-19 Pneumonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2020-01-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research will be retrospective, and will include all patients who were admitted during 2020 and 2021 in the COVID-19 ICU of University Hospital Center Osijek due to pneumonia caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association of chest x-ray infiltrate evolution with changes in laboratory inflammatory parameters and respiratory function parameters will be examined.
Eligibility Criteria
Inclusion Criteria: * Pneumonia caused by SARS-CoV-2 virus * Admission to the ICU COVID-19 unit Exclusion Criteria: \- Patients with lung tumors or history of lung resection
Contact & Investigator
Nenad Nešković, PhD
PRINCIPAL INVESTIGATOR
University Hospital Osijek
Frequently Asked Questions
Who can join the NCT05181696 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying COVID-19 Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05181696 currently recruiting?
Yes, NCT05181696 is actively recruiting participants. Contact the research team at nneskov@gmail.com for enrollment information.
Where is the NCT05181696 trial being conducted?
This trial is being conducted at Osijek, Croatia.
Who is sponsoring the NCT05181696 clinical trial?
NCT05181696 is sponsored by Osijek University Hospital. The principal investigator is Nenad Nešković, PhD at University Hospital Osijek. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.